Patents/Assignees

Hangzhou Highlightll Pharmaceutical Co., Ltd.

3 patents in portfolio

USRE050799reissue2026
JAK1 Selective Inhibitors and Uses Thereof
0 cites
US12195476utility2025
Synthesis Method of Furoimidazopyridine Compound, Crystal Form of Furoimidazopyridine Compound, and Crystal Form of Salt Thereof
0 cites
USRE049834reissue2024
Jak1 Selective Inhibitors and Uses Thereof
0 cites